.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Cantor Fitzgerald
Dow
US Department of Justice
Teva
Covington
Cipla
Federal Trade Commission
Boehringer Ingelheim
Argus Health

Generated: June 27, 2017

DrugPatentWatch Database Preview

SANDIMMUNE Drug Profile

« Back to Dashboard

What is the patent landscape for Sandimmune, and when can generic versions of Sandimmune launch?

Sandimmune is a drug marketed by Novartis and is included in three NDAs.

The generic ingredient in SANDIMMUNE is cyclosporine. There are seventeen drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the cyclosporine profile page.

Summary for Tradename: SANDIMMUNE

Patents:0
Applicants:1
NDAs:3
Suppliers / Packagers: see list1
Bulk Api Vendors: see list82
Clinical Trials: see list13
Patent Applications: see list9,805
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:SANDIMMUNE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis
SANDIMMUNE
cyclosporine
CAPSULE;ORAL050625-001Mar 2, 1990AB2RXYesNo► Subscribe► Subscribe
Novartis
SANDIMMUNE
cyclosporine
INJECTABLE;INJECTION050573-001Nov 14, 1983APRXYesYes► Subscribe► Subscribe
Novartis
SANDIMMUNE
cyclosporine
CAPSULE;ORAL050625-003Nov 23, 1992BXRXYesNo► Subscribe► Subscribe
Novartis
SANDIMMUNE
cyclosporine
CAPSULE;ORAL050625-002Mar 2, 1990AB2RXYesYes► Subscribe► Subscribe
Novartis
SANDIMMUNE
cyclosporine
SOLUTION;ORAL050574-001Nov 14, 1983AB2RXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: SANDIMMUNE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis
SANDIMMUNE
cyclosporine
CAPSULE;ORAL050625-001Mar 2, 19907,511,014► Subscribe
Novartis
SANDIMMUNE
cyclosporine
CAPSULE;ORAL050625-002Mar 2, 19907,511,014► Subscribe
Novartis
SANDIMMUNE
cyclosporine
CAPSULE;ORAL050625-003Nov 23, 19927,511,014► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
Cipla
Argus Health
AstraZeneca
Healthtrust
Covington
Medtronic
Federal Trade Commission
McKesson
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot